Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding

The non-vitamin K antagonist oral anticoagulants (NOACs) have considerably changed clinical practice and are increasingly being used as an alternative to vitamin K antagonists (VKAs) for 3 main reasons: 1) an improved benefit-risk ratio (in particular lower rates of intracranial bleeding), 2) a more...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Wien Klin Wochenschr
Main Authors: Gremmel, Thomas, Niessner, Alexander, Domanovits, Hans, Frossard, Martin, Sengölge, Gürkan, Steinlechner, Barbara, Sycha, Thomas, Wolzt, Michael, Pabinger, Ingrid
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Vienna 2018
Assuntos:
Consensus Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290726/
https://ncbi.nlm.nih.gov/pubmed/30128955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-018-1381-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados